The equipment deal that clears a hospital’s capital committee is won on reimbursement math, the fiscal-year capital cycle, and tax-exempt structure — not on a master lease pitched to a single decision-maker who doesn’t exist.

At a Glance

Selling a health system as one multi-facility account assumes a central decision-maker who rarely holds the authority the org chart implies. Site administrators, service-line chiefs, supply chain, and the capital committee all touch the deal, and each optimizes something different.
Non-profit systems can often access tax-exempt financing a taxable lease can’t beat on economics. A lender who only quotes taxable structures leaves the system’s cheapest option on the table and looks uninformed for it.
The capital committee runs on a fiscal-year cycle and a reimbursement-driven ROI. Equipment that generates billable volume clears on different math than equipment that only reduces cost, and the timing of the ask matters as much as the structure.
Technology obsolescence in imaging and surgical platforms makes refresh rights and mid-life upgrade capacity a real negotiating lever, not a nicety — systems buy into decade-long clinical relationships with these assets.

The Decision-Maker on the Org Chart Doesn’t Decide

The pitch that treats a health system as a single customer with many locations founders on a fact the org chart hides: the person whose title suggests they decide usually can’t, alone. A financing for imaging and surgical equipment across a multi-hospital system touches a site administrator who wants the asset in their building, a service-line chief who wants a specific platform for clinical reasons, a supply-chain or GPO function optimizing for standardization and price, a CFO’s office guarding the balance sheet, and a capital committee that actually allocates. Each optimizes a different variable, and several can veto.

Consider a $7 million package — two MRI systems, a CT, and cath-lab equipment spread across three hospitals in one integrated delivery network. Sold as a single master-lease pitch to the system’s VP of finance, it stalls, because the VP can’t commit clinical platform choices the service-line chiefs own or site priorities the administrators are fighting over. The lender who maps that committee — who knows which chief wants which platform, how supply chain scores standardization, and what the capital committee weighs — is selling to the decision as it’s actually made. The one selling a master lease to a single signature is waiting on a person who doesn’t hold the pen.